Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Cytokinetics, Incorporated

NASDAQ: CYTKHealthcare / Biotechnology / USA
7.68+0.28+3.78%Vol 98 2781Y Perf -3.25%
Dec 10th, 2018 15:02
BID7.68 ASK7.70
Open7.53 Previous Close7.40
Pre-Market- After-Trading7.40
 - -%  - -%
Target Price
14.25 
Analyst Rating
Strong Buy 1.50
Potencial %
85.31 
Finscreener Ranking
     39.35
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
+     33.29
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
     34.93
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
 —    -
Market Cap (mil)420 
Earnings Rating
Price Range Ratio 52wk %
39.15 
Earnings Date
1st Nov 2018

Today's Price Range

7.437.76

 

52wk Range

6.0210.26

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
4.08%
3 Months
-5.73%
6 Months
-13.45%
1 Year
-3.25%
3 Years
-37.07%
5 Years
10.12%

Quotes

Name / TickerPriceChg.Chg.%
CYTK7.680.28003.78
AAPL168.960.47000.28
GOOG1 039.903.32000.32
MSFT106.972.15002.05
XOM75.91-1.7300-2.23
WFC48.80-1.4600-2.90
JNJ145.05-0.3800-0.26
FB142.084.66003.39
GE6.90-0.1100-1.57
JPM101.24-2.0500-1.98
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
10.50
Current Ratio
10.60
Long Term Debt to Total Capital
0.42
Total Debt to Equity
0.80
Interest Coverage
-4.90
Leverage Ratio 3.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-452.00
EBITDA Margin
-442.20
Pre-tax Profit Margin
-242.50
Profit Margin
-96.41
ValuationValueIndustryS&P 500US Markets
PE Ratio
473.30
PB Ratio
8.26
PS Ratios
15.17
Price to Cash Flow
2 571.50
Price to Free Cash Flow
-3.80
Cash Flow Per Share
-2.08
Price to Tangible Book
8.26
Book Value per Share
0.95
Enterprise Value (in ths.)
261 623
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-47.53
ROE last 12 Months
-121.76
Return on Assets (5Y Avg)
-13.61
ROA last 12 Months
-43.49
Return on Capital (5Y Avg)
-36.46
ROC last 12 Months
-76.65
Return on invested Capital Q
-17.78
Return on invested Capital Y
-86.11
Assets Turnover
0.10
Receivables Turnover
3.70
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
28 356
Revenue per Share
0.52
Revenue Growth 3 Years
-13.33
Revenue Growth 5 Years
2.83
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.53-0.4024.53
Q02 2018-0.49-0.51-4.08
Q01 2018-0.53-0.56-5.66
Q04 2017-0.71-0.75-5.63
Q03 2017-0.64-0.606.25
Q02 2017-0.66-0.609.09
Q01 2017-0.11-0.62-463.64
Q04 2016-0.270.16159.26
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.55-5.77Negative
12/2018 FY-1.960.00-
3/2019 QR-0.54-3.85Negative
12/2019 FY-1.7210.88Positive
Next Report Date-
Estimated EPS Next Report-0.53
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume98 278
Shares Outstanding (in ths.)54 710
Trades Count495
Dollar Volume592 716
Avg. Volume341 038
Avg. Weekly Volume279 347
Avg. Monthly Volume357 427
Avg. Quarterly Volume372 088

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

30%70%

Bearish Bullish

74%26%

Bearish Bullish

63%37%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (75.00 %)
3 (60.00 %)
3 (60.00 %)
Moderate Buy
0 (0.00 %)
1 (20.00 %)
1 (20.00 %)
Hold
1 (25.00 %)
1 (20.00 %)
1 (20.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.50
Moderate Buy
1.60
Moderate Buy
1.60

There are no comments yet.

News